Sign in

CIK 0001699382

  • Non-accelerated filer
  • Smaller reporting company

PMV Pharmaceuticals, Inc.

Sign in to watch
Ticker
PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463218129
Phone
+1 609-642-6670
Business address
400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
  1. 4 Grant or award Chief Development Officer acquired 95,555 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 82,220 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 163,890 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale 10% owner sold 87,786 shares at $2.23 ($195,763)
  6. 4 Option exercise President and CEO acquired 198,407 shares (option exercise)
  7. 4 Open-market sale Chief Development Officer sold 4,104 shares at $6.62 ($27,168)
  8. 4 Open-market sale Chief Medical Officer sold 6,291 shares at $6.62 ($41,646)
  9. 4 Option exercise President and CEO acquired 85,500 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Gift COO, CFO gave 2,560 shares (gift)

Page 3 of 10 · 190 filings